Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) or Patients Under Investigation for 2019-nCoV in Healthcare Settings | NLM

Disaster Information Management Research Center | NLM

Interim Infection Prevention and Control Recommendations for Patients with Confirmed 2019 Novel Coronavirus (2019-nCoV) or Patients Under Investigation for 2019-nCoV in Healthcare Settings

02/03/2020 12:00 AM EST

Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 2/3/2020. This guidance, updated on February 3, 2020, is based on the currently limited information available about 2019-nCoV related to disease severity, transmission efficiency, and shedding duration. This cautious approach will be refined and updated as more information becomes available and as response needs change in the United States. This guidance is applicable to all U.S. healthcare settings. This guidance is not intended for non-healthcare settings (e.g., schools) or to persons outside of healthcare settings. (Text)